CIM
AVNS

Confluence Investment Management’s Avanos Medical AVNS Stock Holding History

Confluence Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-466,994
Closed -$20.4M – 303
2021
Q1 		$20.4M Sell
466,994
-14,048
-3% -$659K 0.29% 94
2020
Q4 		$22.1M Sell
481,042
-31,335
-6% -$1.3M 0.33% 87
2020
Q3 		$17M Sell
512,377
-39,817
-7% -$1.27M 0.28% 92
2020
Q2 		$16.2M Sell
552,194
-60,297
-10% -$1.75M 0.27% 90
2020
Q1 		$16.5M Buy
612,491
+497,858
+434% +$14.9M 0.31% 85
2019
Q4 		$5M Sell
114,633
-21,360
-16% -$773K 0.08% 150
2019
Q3 		$5.09M Buy
135,993
+21,360
+19% +$815K 0.08% 148
2019
Q2 		$5M Buy
+114,633
New +$4.9M 0.08% 150
2018
Q3 		– Sell
-108,381
Closed -$6.21M – 312
2018
Q2 		$6.21M Buy
108,381
+492
+0.5% +$26K 0.11% 121
2018
Q1 		$4.97M Buy
107,889
+3,856
+4% +$183K 0.09% 132
2017
Q4 		$4.8M Buy
104,033
+2,579
+3% +$119K 0.09% 134
2017
Q3 		$4.57M Buy
101,454
+1,331
+1% +$56.8K 0.09% 134
2017
Q2 		$3.93M Buy
100,123
+10,871
+12% +$411K 0.08% 145
2017
Q1 		$3.4M Buy
89,252
+15,605
+21% +$608K 0.08% 147
2016
Q4 		$2.72M Buy
73,647
+8,510
+13% +$304K 0.07% 157
2016
Q3 		$2.26M Buy
65,137
+4,186
+7% +$147K 0.06% 171
2016
Q2 		$1.98M Buy
60,951
+1,983
+3% +$60.7K 0.05% 174
2016
Q1 		$1.69M Buy
58,968
+5,034
+9% +$134K 0.05% 177
2015
Q4 		$1.8M Buy
53,934
+3,783
+8% +$118K 0.06% 172
2015
Q3 		$1.43M Buy
50,151
+14,081
+39% +$491K 0.05% 188
2015
Q2 		$1.46M Buy
36,070
+15,036
+71% +$675K 0.05% 191
2015
Q1 		$1.03M Buy
21,034
+933
+5% +$43.2K 0.04% 195
2014
Q4 		$914K Buy
+20,101
New +$790K 0.04% 192

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Confluence Investment Management's AVNS Position: Q2 2021 in Review

Confluence Investment Management sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 466,994 shares — an estimated $20.4M sold.

Confluence Investment Management first reported a position in AVNS in Q4 2014 and held it in 23 quarters. The position peaked at $22.1M in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • Confluence Investment Management reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • Confluence Investment Management sold 466,994 Avanos Medical shares in Q2 2021, an estimated $20.4M.
  • Confluence Investment Management first reported a position in Avanos Medical in Q4 2014 and held it in 23 quarters.
  • Confluence Investment Management's Avanos Medical position peaked at $22.1M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Confluence Investment Management's 13F filing for Q2 2021, filed 1 Jul 2021.